Next Article in Journal
Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment
Next Article in Special Issue
Novel Treatment Strategies Utilizing Immune Reactions against Chronic Myelogenous Leukemia Stem Cells
Previous Article in Journal
The Dual Effect of the BMP9–ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement?
Previous Article in Special Issue
Which Tyrosine Kinase Inhibitors Should Be Selected as the First-Line Treatment for Chronic Myelogenous Leukemia in Chronic Phase?
 
 
Article

Article Versions Notes

Cancers 2021, 13(21), 5413; https://doi.org/10.3390/cancers13215413
Action Date Notes Link
article xml file uploaded 28 October 2021 15:14 CEST Original file -
article xml uploaded. 28 October 2021 15:14 CEST Update https://www.mdpi.com/2072-6694/13/21/5413/xml
article pdf uploaded. 28 October 2021 15:14 CEST Version of Record https://www.mdpi.com/2072-6694/13/21/5413/pdf
article supplementary file uploaded. 28 October 2021 15:14 CEST - https://www.mdpi.com/2072-6694/13/21/5413#supplementary
article html file updated 28 October 2021 15:16 CEST Original file -
article html file updated 30 July 2022 13:40 CEST Update https://www.mdpi.com/2072-6694/13/21/5413/html
Back to TopTop